Clinical Trials Logo

Filter by:
NCT ID: NCT04406857 Terminated - Clinical trials for Rectal Adenocarcinoma

Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer

Start date: March 17, 2021
Phase: Phase 1
Study type: Interventional

This phase I trial studies the side effects and best dose of ropidoxuridine and how well it works when added to the usual chemotherapy treatment (capecitabine) during radiation therapy for the treatment of patients with stage II-III rectal cancer. Ropidoxuridine may help radiation therapy work better by making cancer cells more sensitive to the radiation therapy. Chemotherapy drugs, such as capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out whether ropidoxuridine in addition to capecitabine and radiation therapy works better in treating patients with rectal cancer.

NCT ID: NCT04406740 Terminated - Anesthesia Clinical Trials

Clinical Evaluation of a Novel Neuromuscular Blockade Monitoring System

Start date: June 18, 2018
Phase:
Study type: Observational

This study is designed to formally evaluate the performance of the QTOF, as compared with the newest commercially available NMB monitoring equipment, EMG (the TwitchView).

NCT ID: NCT04406389 Terminated - COVID-19 Clinical Trials

Anticoagulation in Critically Ill Patients With COVID-19 (The IMPACT Trial)

IMPACT
Start date: October 13, 2020
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if therapeutic dose anticoagulation (experimental group) improves 30-day mortality in participants with COVID-19 compared to those patients receiving the intermediate dose prophylaxis (control group). Following screening, subjects will be randomized 1:1 to intermediate dose prophylaxis or therapeutic dose anticoagulation treatment arms.Treatment will continue for 28 days, followed by a 6 month follow-up period.

NCT ID: NCT04404998 Terminated - Feeding Behavior Clinical Trials

The Influence of Energy Density and Information on Meal Intake in Adults

Start date: August 3, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to gain a better understanding of how energy density and cognitive framing of satiation using food information can influence consumption at a meal. This study also aims to investigate the influence of energy density and food information on sensory specific satiety (the decline in the subjective pleasantness of a food as it is eaten).

NCT ID: NCT04404712 Terminated - Clinical trials for Alcohol Use Disorder

FAAH Availability in Psychiatric Disorders: A PET Study

Start date: September 23, 2020
Phase: Early Phase 1
Study type: Interventional

The aim of the present study is to examine Fatty Acid Amide Hydrolase (FAAH) availability in humans, including healthy individuals and across a spectrum of psychiatric disorders in which alterations in the endocannabinoid system are observed.

NCT ID: NCT04404452 Terminated - Heart Failure Clinical Trials

Heart Failure Monitoring With Eko Electronic Stethoscopes

HOME0
Start date: July 6, 2020
Phase:
Study type: Observational

This proof-of-concept study will evaluate the feasibility of the Eko DUO to measure signals relevant to heart failure (HF) decompensation, as well as the feasibility to develop an algorithm to model hemodynamic filling pressures in HF patients under active decompensation in a cardiac intensive care unit (CICU) or coronary care unit (CCU). To also assess the performance of the Eko CORE to detect signals of an HF event, this study will also take heart and lung sound measurements with the Eko CORE.

NCT ID: NCT04404361 Terminated - COVID-19 Clinical Trials

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Start date: May 22, 2020
Phase: Phase 2
Study type: Interventional

This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of pacritinib in hospitalized patients with severe COVID-19 with or without cancer.

NCT ID: NCT04403763 Terminated - Presbyopia Clinical Trials

Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia

Start date: July 27, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

The objective of this study is to evaluate the safety, tolerability, pharmacokinetics, and efficacy of AGN-241622 ophthalmic solution for the first time in human participants

NCT ID: NCT04403282 Terminated - Clinical trials for Pseudofolliculitis Barbae

Topical Eflornithine for Pseudofolliculitis Barbae: Randomized Controlled Trial

Start date: September 27, 2020
Phase: Phase 4
Study type: Interventional

To study the efficacy of topical eflornithine for pseudofolliculitis barbae from a quality of life standpoint and with objective physician-measured lesion counts. Our hypothesis is that the hair growth retardation that occurs with eflornithine will perhaps reduce the frequency over time that service members need to shave which could improve the formation of PFB lesions.

NCT ID: NCT04402385 Terminated - Pre-Eclampsia Clinical Trials

Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)

Start date: August 6, 2020
Phase: Phase 2
Study type: Interventional

To determine if low dose aspirin reduces the incidence of hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia, and HELLP syndrome) in pregnant women with stage 1 hypertension and elevated blood pressure.